Viewing StudyNCT00416884



Ignite Creation Date: 2024-05-05 @ 5:13 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00416884
Status: TERMINATED
Last Update Posted: 2017-09-27
First Post: 2006-12-27

Brief Title: FluAlemtuzumaband TBI Followed By Donor Stem Cell Chronic Phase CML
Sponsor: OHSU Knight Cancer Institute
Organization: OHSU Knight Cancer Institute

Conditions & Keywords Data

Conditions:
Name
Leukemia
Keywords:
Name View
relapsing chronic myelogenous leukemia View
chronic phase chronic myelogenous leukemia View
childhood chronic myelogenous leukemia View